182 related articles for article (PubMed ID: 15771457)
1. Synthesis, structure-activity relationship, and receptor pharmacology of a new series of quinoline derivatives acting as selective, noncompetitive mGlu1 antagonists.
Mabire D; Coupa S; Adelinet C; Poncelet A; Simonnet Y; Venet M; Wouters R; Lesage AS; Van Beijsterveldt L; Bischoff F
J Med Chem; 2005 Mar; 48(6):2134-53. PubMed ID: 15771457
[TBL] [Abstract][Full Text] [Related]
2. Positive and negative modulation of group I metabotropic glutamate receptors.
Vanejevs M; Jatzke C; Renner S; Müller S; Hechenberger M; Bauer T; Klochkova A; Pyatkin I; Kazyulkin D; Aksenova E; Shulepin S; Timonina O; Haasis A; Gutcaits A; Parsons CG; Kauss V; Weil T
J Med Chem; 2008 Feb; 51(3):634-47. PubMed ID: 18173231
[TBL] [Abstract][Full Text] [Related]
3. Discovery and biological profile of 4-(1-aryltriazol-4-yl)-tetrahydropyridines as an orally active new class of metabotropic glutamate receptor 1 antagonist.
Ito S; Satoh A; Nagatomi Y; Hirata Y; Suzuki G; Kimura T; Satow A; Maehara S; Hikichi H; Hata M; Kawamoto H; Ohta H
Bioorg Med Chem; 2008 Nov; 16(22):9817-29. PubMed ID: 18849168
[TBL] [Abstract][Full Text] [Related]
4. New 2-arylpyrazolo[4,3-c]quinoline derivatives as potent and selective human A3 adenosine receptor antagonists.
Baraldi PG; Tabrizi MA; Preti D; Bovero A; Fruttarolo F; Romagnoli R; Zaid NA; Moorman AR; Varani K; Borea PA
J Med Chem; 2005 Jul; 48(15):5001-8. PubMed ID: 16033279
[TBL] [Abstract][Full Text] [Related]
5. JNJ16259685, a highly potent, selective and systemically active mGlu1 receptor antagonist.
Lavreysen H; Wouters R; Bischoff F; Nóbrega Pereira S; Langlois X; Blokland S; Somers M; Dillen L; Lesage AS
Neuropharmacology; 2004 Dec; 47(7):961-72. PubMed ID: 15555631
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and SAR comparison of regioisomeric aryl naphthyridines as potent mGlu5 receptor antagonists.
Galatsis P; Yamagata K; Wendt JA; Connolly CJ; Mickelson JW; Milbank JB; Bove SE; Knauer CS; Brooker RM; Augelli-Szafran CE; Schwarz RD; Kinsora JJ; Kilgore KS
Bioorg Med Chem Lett; 2007 Dec; 17(23):6525-8. PubMed ID: 17936624
[TBL] [Abstract][Full Text] [Related]
7. Identification of substituted 6-amino-4-phenyltetrahydroquinoline derivatives: potent antagonists for the follicle-stimulating hormone receptor.
van Straten NC; van Berkel TH; Demont DR; Karstens WJ; Merkx R; Oosterom J; Schulz J; van Someren RG; Timmers CM; van Zandvoort PM
J Med Chem; 2005 Mar; 48(6):1697-700. PubMed ID: 15771412
[TBL] [Abstract][Full Text] [Related]
8. Novel vanilloid receptor-1 antagonists: 1. Conformationally restricted analogues of trans-cinnamides.
Norman MH; Zhu J; Fotsch C; Bo Y; Chen N; Chakrabarti P; Doherty EM; Gavva NR; Nishimura N; Nixey T; Ognyanov VI; Rzasa RM; Stec M; Surapaneni S; Tamir R; Viswanadhan VN; Treanor JJ
J Med Chem; 2007 Jul; 50(15):3497-514. PubMed ID: 17585749
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological characterization of a new, orally active and potent allosteric metabotropic glutamate receptor 1 antagonist, 4-[1-(2-fluoropyridin-3-yl)-5-methyl-1H-1,2,3-triazol-4-yl]-N-isopropyl-N-methyl-3,6-dihydropyridine-1(2H)-carboxamide (FTIDC).
Suzuki G; Kimura T; Satow A; Kaneko N; Fukuda J; Hikichi H; Sakai N; Maehara S; Kawagoe-Takaki H; Hata M; Azuma T; Ito S; Kawamoto H; Ohta H
J Pharmacol Exp Ther; 2007 Jun; 321(3):1144-53. PubMed ID: 17360958
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and receptor assay of aromatic-ethynyl-aromatic derivatives with potent mGluR5 antagonist activity.
Alagille D; Baldwin RM; Roth BL; Wroblewski JT; Grajkowska E; Tamagnan GD
Bioorg Med Chem; 2005 Jan; 13(1):197-209. PubMed ID: 15582465
[TBL] [Abstract][Full Text] [Related]
11. Potent and specific action of the mGlu1 antagonists YM-298198 and JNJ16259685 on synaptic transmission in rat cerebellar slices.
Fukunaga I; Yeo CH; Batchelor AM
Br J Pharmacol; 2007 Jul; 151(6):870-6. PubMed ID: 17502847
[TBL] [Abstract][Full Text] [Related]
12. Metabotropic glutamate receptor 1 blockade impairs acquisition and retention in a spatial Water maze task.
Steckler T; Oliveira AF; Van Dyck C; Van Craenendonck H; Mateus AM; Langlois X; Lesage AS; Prickaerts J
Behav Brain Res; 2005 Oct; 164(1):52-60. PubMed ID: 16043241
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and characterization of two PET radioligands for the metabotropic glutamate 1 (mGlu1) receptor.
Huang Y; Narendran R; Bischoff F; Guo N; Bae SA; Hwang DR; Lesage AS; Laruelle M
Synapse; 2012 Dec; 66(12):1002-14. PubMed ID: 22927303
[TBL] [Abstract][Full Text] [Related]
14. In vitro pharmacological characterization of novel isoxazolopyridone derivatives as allosteric metabotropic glutamate receptor 7 antagonists.
Suzuki G; Tsukamoto N; Fushiki H; Kawagishi A; Nakamura M; Kurihara H; Mitsuya M; Ohkubo M; Ohta H
J Pharmacol Exp Ther; 2007 Oct; 323(1):147-56. PubMed ID: 17609420
[TBL] [Abstract][Full Text] [Related]
15. Potent nonpeptide antagonists of the bradykinin B1 receptor: structure-activity relationship studies with novel diaminochroman carboxamides.
Biswas K; Li A; Chen JJ; D'Amico DC; Fotsch C; Han N; Human J; Liu Q; Norman MH; Riahi B; Yuan C; Suzuki H; Mareska DA; Zhan J; Clarke DE; Toro A; Groneberg RD; Burgess LE; Lester-Zeiner D; Biddlecome G; Manning BH; Arik L; Dong H; Huang M; Kamassah A; Loeloff R; Sun H; Hsieh FY; Kumar G; Ng GY; Hungate RW; Askew BC; Johnson E
J Med Chem; 2007 May; 50(9):2200-12. PubMed ID: 17408249
[TBL] [Abstract][Full Text] [Related]
16. New 2-arylpyrazolo[3,4-c]quinoline derivatives as potent and selective human A3 adenosine receptor antagonists. Synthesis, pharmacological evaluation, and ligand-receptor modeling studies.
Colotta V; Catarzi D; Varano F; Capelli F; Lenzi O; Filacchioni G; Martini C; Trincavelli L; Ciampi O; Pugliese AM; Pedata F; Schiesaro A; Morizzo E; Moro S
J Med Chem; 2007 Aug; 50(17):4061-74. PubMed ID: 17665891
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, in vitro pharmacology, structure-activity relationships, and pharmacokinetics of 3-alkoxy-2-amino-6-fluorobicyclo[3.1.0]hexane-2,6-dicarboxylic acid derivatives as potent and selective group II metabotropic glutamate receptor antagonists.
Nakazato A; Sakagami K; Yasuhara A; Ohta H; Yoshikawa R; Itoh M; Nakamura M; Chaki S
J Med Chem; 2004 Aug; 47(18):4570-87. PubMed ID: 15317467
[TBL] [Abstract][Full Text] [Related]
18. Metabotropic glutamate 1 receptor: current concepts and perspectives.
Ferraguti F; Crepaldi L; Nicoletti F
Pharmacol Rev; 2008 Dec; 60(4):536-81. PubMed ID: 19112153
[TBL] [Abstract][Full Text] [Related]
19. Structure-activity relationship of triazafluorenone derivatives as potent and selective mGluR1 antagonists.
Zheng GZ; Bhatia P; Daanen J; Kolasa T; Patel M; Latshaw S; El Kouhen OF; Chang R; Uchic ME; Miller L; Nakane M; Lehto SG; Honore MP; Moreland RB; Brioni JD; Stewart AO
J Med Chem; 2005 Nov; 48(23):7374-88. PubMed ID: 16279797
[TBL] [Abstract][Full Text] [Related]
20. Antagonist-induced supersensitivity of mGlu1 receptor signalling in cerebellar granule cells.
Lavreysen H; Willemoens T; Leysen JE; Lesage AS
Eur J Neurosci; 2005 Mar; 21(6):1610-6. PubMed ID: 15845088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
